HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ioannis Psallidas Selected Research

Pleurodesis

1/2022Role of thoracic ultrasonography in pleurodesis pathways for malignant pleural effusions (SIMPLE): an open-label, randomised controlled trial.
11/2021The Association Between Pleural Fluid Exposure and Survival in Pleural Mesothelioma.
1/2020Clinically important associations of pleurodesis success in malignant pleural effusion: Analysis of the TIME1 data set.
1/2020Effect of Thoracoscopic Talc Poudrage vs Talc Slurry via Chest Tube on Pleurodesis Failure Rate Among Patients With Malignant Pleural Effusions: A Randomized Clinical Trial.
11/2019Survival in patients with malignant pleural effusion undergoing talc pleurodesis.
2/2019Does attempting talc pleurodesis affect subsequent indwelling pleural catheter (IPC)-related non-draining septated pleural effusion and IPC-related spontaneous pleurodesis?
1/2019The Hospital and Patient Burden of Indwelling Pleural Catheters: A Retrospective Case Series of 210 Indwelling Pleural Catheter Insertions.
11/2018Thoracic Ultrasound as an Early Predictor of Pleurodesis Success in Malignant Pleural Effusion.
1/2018Randomized Controlled Trial of Urokinase versus Placebo for Nondraining Malignant Pleural Effusion.
1/2018Development and validation of response markers to predict survival and pleurodesis success in patients with malignant pleural effusion (PROMISE): a multicohort analysis.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ioannis Psallidas Research Topics

Disease

25Neoplasms (Cancer)
11/2021 - 10/2007
19Malignant Pleural Effusion
01/2022 - 10/2007
11Infections
01/2022 - 12/2014
11Inflammation (Inflammations)
01/2021 - 03/2009
8Pleural Effusion (Pleural Effusions)
02/2019 - 07/2009
6Pleural Diseases
10/2021 - 10/2007
5Malignant Mesothelioma
01/2022 - 12/2016
5Mesothelioma
10/2021 - 11/2015
4Chronic Obstructive Pulmonary Disease (COPD)
01/2022 - 01/2019
3Asthma (Bronchial Asthma)
01/2021 - 09/2020
3Adenocarcinoma of Lung
12/2020 - 03/2010
3Carcinogenesis
12/2020 - 12/2011
3Pain (Aches)
01/2020 - 12/2015
2Weight Loss (Weight Reduction)
11/2021 - 05/2011
2Dyspnea (Shortness of Breath)
01/2020 - 01/2018
2Neoplasm Metastasis (Metastasis)
01/2019 - 01/2017
2Fibrosis (Cirrhosis)
01/2018 - 05/2011
2Lung Neoplasms (Lung Cancer)
06/2016 - 03/2010
2Hydrothorax
03/2015 - 07/2010
2Cachexia
05/2011 - 03/2009
2Lewis Lung Carcinoma
03/2010 - 01/2009
1Coinfection
01/2022
1Contusions
09/2020
1Sepsis (Septicemia)
01/2019
1Disease Progression
01/2018
1Immunoglobulin G4-Related Disease
11/2017
1Circulating Neoplastic Cells
01/2017
1Pneumothorax
01/2017
1Bites and Stings (Sting)
01/2017
1Pleural Tuberculosis
07/2015
1Colonic Neoplasms (Colon Cancer)
06/2015
1Adenocarcinoma
06/2015

Drug/Important Bio-Agent (IBA)

6Biological ProductsIBA
01/2022 - 01/2017
5AZD-8871IBA
01/2022 - 01/2019
5TalcFDA Link
01/2020 - 01/2018
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2013 - 10/2007
4Bronchodilator Agents (Bronchodilators)IBA
01/2022 - 01/2019
4OsteopontinIBA
12/2020 - 07/2009
4Pharmaceutical PreparationsIBA
11/2020 - 03/2010
3AsbestosIBA
01/2022 - 12/2016
3Biomarkers (Surrogate Marker)IBA
10/2021 - 01/2018
3Deoxyribonucleases (DNase)FDA Link
01/2019 - 12/2014
3Tissue Plasminogen Activator (Alteplase)FDA Link
01/2019 - 12/2014
3ChemokinesIBA
01/2017 - 01/2009
3NF-kappa B (NF-kB)IBA
11/2015 - 10/2007
2Muscarinic AntagonistsIBA
01/2022 - 09/2020
2Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 10/2018
2CarcinogensIBA
12/2020 - 04/2012
2CytokinesIBA
08/2013 - 10/2007
2Bortezomib (Velcade)FDA Link
04/2012 - 03/2010
2Urethane (Ethyl Carbamate)IBA
04/2012 - 12/2011
2Proteasome Endopeptidase Complex (Proteasome)IBA
04/2012 - 03/2010
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2011 - 10/2007
2Proteins (Proteins, Gene)FDA Link
07/2009 - 07/2008
1GSK573719IBA
01/2022
116S Ribosomal RNAIBA
01/2022
1vilanterolIBA
01/2022
1Hemoglobins (Hemoglobin)IBA
11/2021
1Serum AlbuminIBA
11/2021
1AZD1419IBA
01/2021
1Toll-Like Receptor 9IBA
01/2021
1Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2021
1Urea (Carbamide)FDA LinkGeneric
11/2020
1AlbuminsIBA
11/2020
1Adrenergic Receptors (Adrenergic Receptor)IBA
09/2020
1Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA
09/2020
1ProlactinIBA
11/2019
1dornase alfa (Pulmozyme)FDA Link
01/2019
1C-Reactive ProteinIBA
01/2018
1Dihydrotachysterol (AT 10)IBA
01/2018
1Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
01/2018
1Immunoglobulin G (IgG)IBA
11/2017
1Epithelial Cell Adhesion MoleculeIBA
01/2017
1Bevacizumab (Avastin)FDA Link
01/2017
1PyrazinamideFDA LinkGeneric
07/2016
1Opioid Analgesics (Opioids)IBA
12/2015
1Opiate AlkaloidsIBA
12/2015
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
12/2015
1Sirolimus (Rapamycin)FDA Link
11/2015
1temsirolimusFDA Link
11/2015
1Adenosine DeaminaseIBA
07/2015
1Interleukin-27 (Interleukin 27)IBA
07/2015
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
07/2015
1Tryptases (Tryptase)IBA
06/2015
1Imatinib Mesylate (Gleevec)FDA Link
06/2015
1Analgesics (Analgesic Drugs)IBA
03/2015
1Ibuprofen (Motrin)FDA LinkGeneric
03/2015
1Bovine Serum AlbuminIBA
03/2015
1parecoxibIBA
03/2015

Therapy/Procedure

14Pleurodesis
01/2022 - 12/2015
5Catheters
11/2020 - 07/2015
5Therapeutics
04/2019 - 12/2014
4Radiotherapy
01/2020 - 01/2018
3Drug Therapy (Chemotherapy)
11/2021 - 01/2018
3Chest Tubes (Chest Tube)
01/2020 - 12/2015
2Analgesia
01/2020 - 12/2015
2Palliative Care (Palliative Therapy)
01/2019 - 12/2016
1Punctures
09/2020
1Indwelling Catheters (Indwelling Catheter)
01/2018
1Thoracotomy
03/2015